Assessment of Prior Opioid Tolerance Among New Users of Fentanyl Transdermal System in FDA’s Sentinel System

Project Title	Assessment of Prior Opioid Tolerance Among New Users of Fentanyl Transdermal System in FDA’s Sentinel System
Date	Wednesday, October 31, 2018
Location	Pharmacoepidemiol Drug Saf. 2018 Oct 31. doi: 10.1002/pds.4677
Description	Fentanyl transdermal system (FTS) is intended only for patients with prior opioid tolerance. The purpose of this study is to identify the proportion of new FTS users who had evidence of prior opioid tolerance, by dosage strength, in FDA's Sentinel System.
Medical Product	fentanyl transdermal system
Corresponding Author	Noelle M. Cocoros, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, 401 Park Drive, Suite 401 East, Boston, MA 02215, USA. Email: noelle_cocoros@harvardpilgrim.org
Authors	Noelle M. Cocoros, Marc R. Larochelle, Jennifer Popovic, Andrew B. Petrone, Cynthia Kornegay, Jing Ju, Judith A. Racoosin
Related Assessments	2017 ICPE Presentation: Assessment of Prior Opioid Tolerance Among New Users of Fentanyl Transdermal System in FDA's Sentinel System Counts and Proportions of New Users of Fentanyl Transdermal System with Evidence of Prior Opioid Tolerance
Publication Type	Publication

Search form